Detaylı Arama

İptal
Bulunan: 2 Adet 0.001 sn
- Eklemek veya çıkarmak istediğiniz kriterleriniz için 'Dahil' / 'Hariç' seçeneğini kullanabilirsiniz. Sorgu satırları birbirine 'VE' bağlacı ile bağlıdır.
- İptal tuşuna basarak normal aramaya dönebilirsiniz.
Filtreler
Süresiz Ambargo

A randomized controlled trial on pain, grip strength, and functionality in lateral elbow pain: Mulligan vs muscle energy techniques

ÜNÜVAR, Bayram Sönmez | BAĞÇACI, Sinan | GERÇEK, Hasan | UĞURLU, İbrahim | AKKOYUN SERT, Özlem | YILMAZ, Kamil

BACKGROUND: Lateral elbow tendinopathy (LET) is one of the most common lesions of the upper extremity. The level of evidence from studies on LET treatment protocols is insufficient. OBJECTIVE: The aim of this study was to compare the acute effects of mobilization with movement (MWM) and muscle energy technique (MET) on pain, grip strength, and functionality in patients diagnosed with LET. METHODS: Forty-five patients with LET aged 30–55 years were enrolled in this study. Patients were divided into three groups: MWM, MET, and control group. The control group received a 4-week home exercise prog ...Daha fazlası

Erişime Açık

Mid- and Long-Term Effect of Kinesio Taping on Temporomandibular Joint Dysfunction: A Randomised- Controlled Trial

ÜNÜVAR, Bayram Sönmez | ÖZMEN, Elif Esra | DURMUŞ, Ercan | KALAYCI, Abdullah

Purpose: This study aimed to determine the mid- and long-term effects of Kinesio-taping (KT) on individuals with temporomandibular joint disorders (TMD). Methods: Thirty-three patients were randomly divided into two groups: group 1 is control; group 2 is KT group. KT treatment was applied in six sessions (one session/week) for 6 weeks. At 6 months, the visual analogue scale (VAS) values and range of motion of the jaw before and after the treatment were recorded. Results: After the treatment in both groups, a statistically significant decrease in pain VAS values of the lateral pterygoid and mas ...Daha fazlası

6698 sayılı Kişisel Verilerin Korunması Kanunu kapsamında yükümlülüklerimiz ve cerez politikamız hakkında bilgi sahibi olmak için alttaki bağlantıyı kullanabilirsiniz.

creativecommons
Bu site altında yer alan tüm kaynaklar Creative Commons Alıntı-GayriTicari-Türetilemez 4.0 Uluslararası Lisansı ile lisanslanmıştır.
Platforms